USPTO 2015–2025 USPTO PatentsView US Corporation

The Tranzonic Companies

USPTO PatentsView assignee record - 23 granted patents across 12 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, The ranks #13,200 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 12 technology areas.

#13,200
of 49,997 US assignees by volume
Top 46%
by Innovation Score (36.5/100)
15.7
avg claims per patent
+129%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13200 · US Corporation #13,200 · 23 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 23 grants
  • MID-PACK #13,200/49,997
  • PHOTO-FINISH The Industry &…
  • CPC-FOCUS A61F · 12 areas
  • INNOV-THIN 36.5/100
  • CLAIMS-RICH 15.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +129% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: The Industry & Academic Cooperation in Chungnam National University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How The’s 36.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around The

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows The's Innovation Score is 36.5/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for The?

Each dot is one of The’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). The’s own 15.7 claims/patent is at or below the 17.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

The vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 22.922.92323.1 510152025 Granted patents (volume) Avg claims / patent The Industry & Academic Cooperation in Chungnam National University - 23, 7.96The Industry & Ac…The Kitasato Institute - 23, 14.35The Kitasato Inst…The National Institute for Biotechnology in the Negev Ltd. - 23, 11.91The National Inst…The Pokémon Company - 23, 22.17The PokémonThe United States of America, as Represented by the Secretary of Commerce National Institute of Standards and Technology - 23, 17.48The United States…Theai, Inc. - 23, 19.04TheaiThinKom Solutions, Inc. - 23, 18.13Thinkom SolutionsTidalX AI Inc. - 23, 18.78Tidalx AIThe Tranzonic Companies - 23, 15.7The Tranzonic Com…
The vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where The's grants concentrate

The Tranzonic Companies is a focused PatentsView assignee: 12 CPC subclasses with 65.2% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2021 (6 grants) versus a trough of 1 in 2024. By volume, The sits between The Industry & Academic Cooperation in Chungnam National University and TidalX AI Inc..

The's three-year grant acceleration

The Tranzonic Companies shows 7 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at The's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows The holds 23 patents at rank #13,203, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near The

By rank, the assignees closest to #13,203 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in The's primary technology class.

The's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 46% higher than 54% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20172018201920202021202220232024 1
USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
The Tranzonic Companies patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 8.7%
2018 2 8.7%
2019 3 13.0%
2020 3 13.0%
2021 6 26.1%
2022 3 13.0%
2023 3 13.0%
2024 1 4.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

The Tranzonic Companies's patent record in context - here's where to go next.

  • The Tranzonic Companies's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 65.2% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #13,200 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare The Tranzonic Companies against The Industry & Academic Cooperation in Chungnam National University, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.